Synthesis and evaluation of airway targeted plga nanoparticles for drug delivery in obstructive lung diseases

Methods in Molecular Biology

Volumn 906, Issue , 2012, Pages 303-310

  Vij, Neeraj ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; CF; COPD; Inflammation and lung disease; PLGA nanoparticles; Therapeutics

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; AMINOPYRIDINE DERIVATIVE; LACTIC ACID; LUMACAFTOR; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CHEMISTRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG DELIVERY SYSTEM; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; METABOLISM; SYNTHESIS; ULTRASTRUCTURE;

AMINOPYRIDINES; BENZODIOXOLES; DRUG DELIVERY SYSTEMS; EPITHELIAL CELLS; HUMANS; LACTIC ACID; LUNG DISEASES, OBSTRUCTIVE; NANOPARTICLES; POLYGLYCOLIC ACID; TRANSFECTION;

EID: 84864852120     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-953-2_24     Document Type: Article

References (4)

1. Vij N, Min T, Marasigan R et al (2010) Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fi brosis. J Nanobiotechnology 8:22
2. Roy I, Vij N (2010) Nano-delivery in airway diseases: challenges and therapeutic applications. Nanomedicine 6(2):237-44
3. Vij N (2011) Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential. Expert Opin Drug Deliv 8:1105-1109
4. Gref RY, Minamitake MT, Peracchia V et al (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600-1603